|Articles|November 1, 2019
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec’s 2020 Pipeline Reportover 6 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forceover 6 years ago
The Pace of Massive Innovationover 6 years ago
The Quest to Measure Drug Effectivenessover 6 years ago
Biosensors in Pharma: A Dose of Optimismover 6 years ago
Closing the Science and Manufacturing Divideover 6 years ago
Country Report: SwedenNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
How are US Regulatory Actions Impacting Pricing?
5